SuiW,OuM,ChenJ,WasY,PengH,QiM, 2009.Comparison of immunohistochemistry (IHC) and fluorescence In Situ hybridization (FISH) assessment for Her-2/neu status in breast cancer,World J Surg Oncol 7 83 -
NikhraP,PatelS,TaviadD,ChaudharyS., 2014.Study of ER (estrogen receptor), PR (progesterone receptor) & Her-2/Neu (human epidermal growth factor receptor) expression by immunohistochemistry in breast carcinoma,IJBAR 5 275 -8
KoseogluRD,MuslehiddinogluA,ErkorkmazU,CaferlerJS,DurerP,OzonYH, 2011.An analysis of Her-2/Neu gene status in invasive ductal carcinomas using immunohistochemistry and fluorescence In Situ hybridization,Turk J Med Sci 41 809 -19
FitzgibbonsPL,DillonDA,AlsabehR,BermanMA,HayesDF,HicksDG, 2014.Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast,Arch Pathol Lab Med 138 595 -601
VarshneyD,ZhouYY,GellerSA,AlsabehR, 2004.Determination of HER-2 status and chromosome 17 polysomy in breast carcinomas comparing hercep test and pathVysion FISH assay,Am J Clin Pathol 121 70 -7
GoudKI,DayakarS,VijayalaxmiK,BabuSJ,VijayAR, 2012.Evaluation of HER-2 /neu status in breast cancer specimens using immunohistochemistry (IHC) and fluorescence in-situ hybridization (FISH) assay,Indian J Med Res 135 312 -7
SaglicanY, 2015.Her-2/neustatus in breast cancer specimens: comparison of immunohistochemistry (IHC) and flourescence In Situ hybridization (FISH) Methods,Int J Morphol 33 737 -42
MoatterT,AbanM,IqbalW,AzamI,PervaizA,SiddiquiF, 2011.Status of HER-2/NEU amplification, polysomy17 and histopathological features of 425 Pakistani breast cancer patients,Asian Pac J Cancer Prev 12 3069 -73
NassarA,KhoorA,RadhakrishananR,RadhakrishnanA,CohenC, 2014.Correlation of Her-2/neu overexpression with gene amplification and its relation to chromosome 17 aneuploidy: A 5-year experience with invasive ductal and lobular carcinomas,Int J Clin Exp Pathol 7 6254 -61
MostafaNA,EissaSS,BelalDM,ShomanSH, 2011.Assessment of Her-2/Neu gene amplification status in breast carcinoma with equivocal 2+ Her-2/Neu immunostaining,J Egypt Natl Canc Inst 23 41 -6
Ivkovic-KapiclT,Knezevic-UsajS,Djilas-IvanovicD,PanjkovicM., 2007.Correlation of Her-2/Neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer,Anticancer Res 21 673 -8
KuoSJ,WangBB,ChangCS,ChenTH,YehKT,LeeDJ, 2007.Comparison of immunohistochemical and flourescence In Situ hybridization assessment for HER-2/NEU status In Taiwanese breast cancer patients,Taiwan J Obstet Gynecol 46 146 -51
MurthySS,SandhyaDG,AhmedF,GoudKI,DaynalM,SuseelaK, 2011.Assessment of Her-2/neu status by fluorescence In Situ hybridization in immunohistochemistryequivocal cases of invasive ductal carcinoma and aberrant signal patterns. A study at a tertiary cancer center,Indian J Pathol Microbiol 54 532 -38
GhaffariSR,SabokbarT,DastanJ,RafatiM,Moossavi S, 2011.Her-2/neu amplification status in Iranian breast cancer pateitns: comparison of immunohistochemistry (IHC) and flourescence In Situ hybridization (FISH),Asian Pac J Cancer Prev 12 1031 -4
VargaZ,NoskeA,RamachC,PadbergB,Moch H, 2013.Assessment of Her-2/neu status in breast cancer: Overall positivity rate and accuracy by flourscence In Situ hybridization and Immunohistochemistry in a single institution over 12 years: a quality control study,Bio Med Central 30 13 -615
SarodeVR,XianQD,ChristieA,CollinsR,RaoR,LeitchAM, 2015.Evaluation of Her-2/neu by immunohistochemistry using computer based image analysis and correlation with gene amplification by fLourescence In Situ hybridization assay: A 10 years experience and impact of test standardization on concordance rate,Arch Pathol Lab Med 139 922 -8
PanjwaniP,EpariS,KarpateA,ShirsatH,RajsekharanP,BasakR, 2010.Assessment of HER-2/neu status in breast cancer using fluorescence In Situ hybridization & immunohistochemistry: Experience of a tertiary cancer referral centre in India,Indian J Med Res 287 -94
SinghaiR,PatilV,PatilA,Immunohistochemical (IHC), 2011.HER2/Neu and flourescentIn Situ hybridization (FISH) gene amplification of breast cancer in Indian women,Asian Pac J Cancer Prev 12 179 -83
AL KhattabiH,KelanyA,BuhmeidaA,Al MaghrabiJ,LariS,ChaudharyA, 2010.Evaluation of HER-2/Neu gene amplification by flourescence In Situ hybridization and immunohistochemistry in Saudi female breast cancer,Anticancer Res 30 4081 -8
PayandehM,SadeghiE,KoohianAK, 2014.Comparison of IHC, FISH, ER and PR in breast cancer in Western Iran,Am J Prev Med 2 37 -41
Garcia-CaballeroT,MenendezMD,Vazquez-BoqueteA,GallegoR,FortezaJ,FragaM., 2006.HER-2 status determination in breast carcinomas. A practical approach,Histol Histopathol 21 227 -36
GrimmEE,SchmidtRA,SwansonPE,DintzisSM,AllisonKH, 2010.Achieving 95% cross-methodological concordance in Her2/neu Testing,Am J Clin Pathol 134 284 -92
EswaracharyV,MohammedIG,JayannaPK,PatilOkalyGV,NargundAR,DhondalayGK, 2017.Her-2/neu testing in 432 consecutive breast cancer cases using FISH and IHC-A comparative study,JDCR 11 EC01 -5
PalaEE,ZekiogluO,ÖzdemirN,YilmazR,KapkacM., 2010.Comparison of immunohistochemistry and fluorescence In Situ hybridization for the analysis of Her-2/neu and iopoisomerase II-alpha status in human breast cancer,Turk J Pathol 26 222 -9